Before the World New Cancer Drug Conference was published, public opinion counterattacks with major academic journals and experts had already begun.
The purpose is not to let this conference journal affect their company.
The influence of the NMPA company is very great, with the help of huge sums of money to clear the way, smooth relations, and many other means.
All of a sudden!
Many well-known international cancer journals have begun reporting on NMPA's latest sequencing.
The NMPA company has also recently launched the "2+ Era" statement.
They believe that third-generation sequencing cannot progress so quickly, which is where many problems lie in genetic engineering.
The 2+ era is the current mainstream direction and trend of gene sequencing.
"Then, find professional experts to criticize Chen Nan!"
"So I don't think this is just a crisis."
Qin Shiming patted Chen Nan on the shoulder, looked at him seriously and said, "Thank you!"
More and more oncologists or experts have begun to join this dispute.
But now, they have no retreat.
After Tashi saw it, his face suddenly turned pale.
Immediately afterwards, they saw the titles of Chen Nan's two papers on the cover of The Lancet.
Time is fermenting every day.
Many domestic medical and pharmaceutical companies have also jumped out to oppose this move.
"We all think that the other party really has third-generation sequencing technology."
"Moreover, Chen Nan's current remarks are just speculation. If he really had an idea, he would have started a counterattack in a highly influential magazine!"
The readers of The Lancet are a group of crazy militants.
"No, Mr. Bird!"
"Find our colleagues to refute each other!"
The manager suppressed his inner excitement and said:
"The Lancet!"
"Bang bang bang!"
However, he still couldn't understand his hatred.
Hearing Chen Nan's words, Qin Shiming suddenly became excited.
Will the Dragon Slayer eventually become a new evil dragon one day?
Chen Nan asked Miao Yuanhua to submit it for examination...
With the strong influence of NMPA, various journals are vying for front page headlines in this new year.
At this point, Morton suddenly paused for a moment and continued: "President, I don't think you need to worry too much!"
The person in charge of the British Drug Administration: "NMPA has always been a gene sequencing company that I trust. I trusted it in the past, but... I don't dare to do it now!
Bird has always believed that China's technology relies on the support of NMPA and is inseparable.
"What's more, they are now working with us on some project research and development work."
He can now clearly feel that the company has encountered a big problem at this time!
As a certification company, NMPA’s more profitable means are genetic testing projects and commissioned projects from pharmaceutical companies.
At this moment.
…
Morton said: "I have united with the pharmaceutical companies that I cooperate with and the medical companies that are testing, and they have all submitted reports to the above!"
But now, the Chinese market is the one where pharmaceutical companies are developing most frequently.
For a time, many cancer researchers were confused after seeing Chen Nan’s comments about the cooperation between the two companies in developing new drugs.
Chen Nan quickly contacted Kong Xu, who was engaged in genetic engineering in the UK, and asked him to meet Qin Shiming.
Even more terrifying than the influence of "Tumor Discovery"!
After all, this is a key conference in world-class oncology.
After Bird heard this, he immediately became angry and tore up the books and notebooks on the table in front of him.
This is an extremely irresponsible thing for patients."
"We are not afraid of losing!"
I have to say that Morton really knows himself very well and knows what he is worried about.
"Their current level can only be said to be average."
""Progress and Development of Gene Sequencing in the 2+ Era"!"
Just when many people are curious.
When Morton heard this, he couldn't help but panic in his heart.
After Bird finished reading the article, he closed his eyes and fell into deep thought.
On the professional oncology forum.
Qin Shiming will definitely agree without hesitation.
This sentence!
This time, these reports, which were like snowflakes, disappeared like nothing!
The other party just said lightly: "As long as it is beneficial to the people and the country, we must persist!"
"But... is this possible?"
Could it be...
Germany’s statement this time can be said to be of great weight!
He could even predict what kind of sensation the Lancet would cause when it was published!
Too cruel!
Chen Nan is really cruel!
However, who is Bird, he can still calm down about this matter.
As time passes slowly like an hourglass.
It directly named both parties as not having the ability to intervene early and treat the precursors of tumors.
It wasn't until he read the second article that Tashi fell into a bit of a struggle.
In fact, Bird is also thinking about a retreat.
Morton smiled slightly: "I have been in China for a long time, and I understand China better. This kind of thing, even if Qin Shiming and others cannot be punished, will still influence their decision."
…
"When the new one comes in, we can show some good intentions and start cooperating again!"
"I never thought that Qin Shiming and Liao Wenkai would cancel it directly, without any room for relaxation!"
But!
That is...whether the NMPA company has the ability to serve as the testing agency of these countries!
The first is Chen Nan’s attack on the “improved car-t model launched by Gilead and NMPA”.
And this time!
domestic!
…
Perhaps, the original NMPA company was about precision medicine and was meant to usher in a new era.
Think that the other party is adding more mistakes to the mistakes.
What’s more, whoever abandons me will not be able to stay the same as yesterday!
Qin Shiming put on airs and said deliberately slowly: "Sorry, our cooperation has been cancelled."
"Director Qin, we can help you build and develop genetic engineering medicine."
"Even forcing him to abdicate!"
"There's obviously something fishy about this!"
Oncologists from all over the world have begun to read this journal seriously.
The World New Cancer Drug Conference, as the only new drug conference in cancer conferences, represents the future trend of cancer drugs.
"All departments, start taking action!"
There are also more and more reports.
"There is no way that third-generation sequencing will appear in one day, and second-generation sequencing will still be the core!"
Chen Nan nodded: "Although I don't know how to do it, there are people who do!"
"The top priority now is to delay!"
But now?
Over time, more and more experts, countries, and organizations have joined this discussion.
"Cancel cooperation!"
The influence of "The Lancet" can definitely be ranked in the top three!
But it’s a coincidence!
At this time, "The Lancet" published such a title.
If publishing the journal of the World Cancer Drug Conference is the first shot in starting this battle.
"Something happened!"
"Their latest targeted drugs are also the result of second-generation sequencing!"
The World New Oncology Drug Conference also soon published the latest journal!
They are the link closest to the patient and the link easiest to get close to the truth!
When everyone saw Chen Nan refuting that second-generation sequencing was immature and limited by its own shortcomings.
The 2+ era launched by NMPA has also begun to be considered a scam!
He knew very well that there was no doubt that Mr. Miao Dingfu's condition was pre-cancerous.
However, things are different now. The flames of war have spread.
Suddenly everyone began to reminisce and reflect.
And he did not shy away from pointing out the shortcomings and loopholes of NMPA's second-generation sequencing.
This is the entry of the national team!
Before, it was just drizzle.
But, now!
"There are indeed problems with second-generation sequencing, but...this is what will inevitably happen in the development of medicine, and this is also the law of medical development!"
Everyone has to admire Chen Nan's "hit the nail on the head!"
These two papers can be said to directly target the NMPA company without any hesitation!
At The Lancet, experts gather together.
but!
Suddenly, the Chinese National Health Commission officially released an announcement.
Chen Nan is one against two, and they are the two top companies in the pharmaceutical field in the world.
After a while!
…
Now, everyone opens their laptops or tablets and begins to read carefully the latest new year's first issue of "The Lancet".
"I want to see if they have any chance to resist this time!"
Although, most oncologists do not understand these scientific research methods and technologies.
"But I'm afraid there is no hope."
"Analysis of Error Rate of Second-Generation Sequencing Gene Testing by NMPA Company"
"NMPA Precision Medicine predicts that the 2+ era is coming!"
As a comprehensive medical journal, it is not easy to have an impact factor of about 30 points!
The most important thing is...
The Lancet is a medical academic journal, but it often expresses dissatisfaction with many international issues.
The development of medicine is inherently limited. Any small progress will change the current medical situation!
I believe that NMPA’s certification is still the industry leader!”
Qin Shiming clenched his fists, eager to try, and nodded excitedly: "I promise to complete the task!"
Seeing that the president was silent, the office was also very dull.
Tashi, who was once a veteran of NMPA, seems to have discovered a problem. With the development of the company, now it has become an object of disgust for him.
so!
When the journal was released, it immediately aroused crazy discussions in the oncology academic circle.
The other party relented!
All the grievances I had felt before seemed to be vented at this moment!
"Just do it! Let go and be brave!"
Chinese?!
Qin Shiming, on the other hand, smiled lightly.
"but!"
So say!
And this time!
The NMPA did not initiate a surrender.
Bird suddenly opened his eyes. At this time, he was completely different from before.
Qin Shiming was a little unclear about Kong Xu at first.
Everyone in the conference room was actually stunned just now.
When Kong Xu appeared with real data, Qin Shiming knew that the counterattack was coming!
And this time!
Internationally, there has been a crazy discussion about second-generation sequencing and NMPA.
It is Qin Shiming's military order.
When everyone is full of doubts about China's genetic engineering.
but!
"Look!"
Even after reading it, I felt a sense of enlightenment and enlightenment.
It can be said that although this journal does not have any impact factor, its influence is very high!
For many patients, once missed, the best treatment cycle may be lost.
Pfizer spokesperson: "Third-generation sequencing is still just a fantasy and unrealistic. I am not denying Chen Nan's correctness, but I have some doubts... Is it really time to start third-generation sequencing now?"
"I can introduce you."
NMPA Corporation will soon be unable to sit still!
Bird was sitting in the office, looking gloomy and uncertain.
Everyone’s experience and feelings come from clinical practice.
"Criticize Chinese genetic engineering for me."
Perhaps, the impact factor of The Lancet is not the highest.
Hope we can communicate with each other.
Because he knows very well that if he gives up cooperation with China, it will encounter big problems for NMPA's realization.
Moreover, there are many masters among them!
Therefore, after hearing the manager's words just now, many people in the room were already feeling a little nervous.
Waiting for an opportunity!
This is not...
During this period, the company is very sensitive and everyone is busy. Any disturbance can make everyone nervous.
Everyone suddenly began to reflect.
"President, I didn't do it well!"
But, what to do?
Bird began to think crazily.
As expected.
The added content is undoubtedly a matter of second-generation sequencing and NMPA.
And everyone in the room couldn't help but feel their hearts twitching.
But an error!
…
To be more precise, are we capable??”
But inside, he was extremely excited!
This is not Bird's character.
And now!
Many countries in the EU have taken the initiative to stand up and refute the NMPA.
Suddenly there was a rapid knock on the door.
Everyone even thinks that this is Qin Shiming's impulsive behavior.
Moreover, this is the first issue of the new year!
"However, the good news for me is that the person in charge of the other party is Chinese!"
Let’s see who can’t calm down first!
"How's your work going?"
Now that he has third-generation sequencing, why do I still need second-generation sequencing?
Because there are so many errors in second-generation sequencing technology, the other party did not introduce it in detail.
Bird nodded: "Well, okay, well done!"
Hearing Bird's words, everyone around them trembled inwardly. Everyone knew that the crisis was coming!
The battle needs to begin!
Moreover, the key is that Chen Nan's remarks can easily attract attention.
One is Gilead, an upstart in the oncology market.
"Morton!"
But still no one spoke in the office.
"It doesn't affect us."
"But... for a third-generation sequencing that is currently in the stage of overcoming technical difficulties, this is still just a beautiful dream. I do not support false fantasies!"
As the winner of this year's Most Anticipated Drug Award, Chen Nan's icariin has naturally become the center of discussion.
Instead, they joined forces with major pharmaceutical companies and some colleagues and experts in the field of genetic sequencing to start a counterattack.
In fact, everyone has begun to reflect on whether NMPA's second-generation sequencing is mature and capable of early intervention and prevention of tumors.
He nodded to the manager beside him: "Well done!"
Bird heard this and nodded.
The rapid knocking on the door immediately made Bird frown slightly.
Soon, a large number of opinions supporting the 2+ era appeared on the Internet. I didn’t believe it at all when it came to third-generation sequencing!
"I think!"
A feeling of despair began to appear in everyone's heart.
I don’t know much about second-generation sequencing either.
More and more experts have come forward and begun to support Chen Nan.
and!
This result was unexpected by everyone.
"Qin Shiming, you are the person in charge, and you did the right thing this time!"
As the topic becomes more and more popular, the disputes become louder and louder.
If we cannot survive safely, NMPA will definitely be severely affected.
Some doctors may have had some doubts about NMPA's accurate sequencing before, but... due to the influence and brand of the other company, they will only reflect on it.
Tashi really didn't want to admit this until he saw Miao Dingfu's latest certification result information...
“Send the article to everyone present!”
When NMPA Company continues to create 2+ era information.
While talking, the manager quickly put the tablet in his hand on the table.
"Because, I think... we may be too full of unrealistic illusions about Chen Nan, which makes us fall into passivity."
Bird also knows that now we really need to stall China.
"Furthermore, there is another problem. Without third-generation sequencing, all our assumptions will be false.
Is it really, as Chen Nan said, a problem with second-generation sequencing technology?
"Even if not, Qin Shiming can still have a pot of it."
The gold content of Chen Nan's two papers is too high.
"But, Director Qin, you have to discuss the details."
After the secretary hurriedly opened the door, he saw a manager of the company standing at the door hurriedly, saying breathlessly: "It's not good!"
"What's the reaction from China?"
Regarding the second-generation sequencing, I directly criticized the NMPA company for its inaction and deliberate concealment of data!
Qin Shiming directly canceled the cooperation with NMPA.
This title really made Bird's eyelids jump.
NMPA, a long-established genetic testing company.
His emergence broke the near-monopoly market held by oncology pharmaceutical companies and ushered in a new era.
Some doctors never even imagined that many patients had undergone sequencing before, but... they still got cancer in the end, and the key reason is that there was no problem with their test results first!
"We have completed the review and inspection of the third-generation sequencing!"
Regarding the shortcomings of second-generation sequencing technology, the inaccuracies of NMPA's sequencing... and so on, problems are beginning to emerge!
Bird looked at the cover at this time, his eyes suddenly filled with fierceness.
“We will proceed with the judgment of the International Court of Justice!”
“They put Chen Nan’s two latest articles on the cover.”
"Bang bang bang!"
Could it be...that they really have third-generation technology?
Thinking of this, Tashi even trembled a little.
therefore!
The Lancet is definitely on the list.
Morton took a deep breath and said helplessly:
"Qin Shiming and Liao Wenkai are indeed a little too partial to Chen Nan."
But……
The academic point of view is sharp and sharp.
After all Chen Nan's views were written out in the "Proceedings of the World New Cancer Drug Conference".
Then negotiate the terms again.
…
“Let’s take a look at the two articles published by Chen Nanxin.”
What are you trying to get involved with at this time?
When it comes to the medical field, which journals and magazines are the boldest.
It's just that... Morton hasn't finished speaking yet.
The EU itself is not highly dependent on NMPA companies.
More and more people are beginning to come forward and doubt NMPA.
After they left, Qin Shiming found Chen Nan in person this time.
Chen Nan's performance of not fearing power has naturally won the support of many people!
Lancet...Lancet!
Time has passed an hour.
but!
This is not an error on their part.
If it were placed before.
Bird's words made everyone become more serious.
"Mr. Bird, because this is a contract you have unilaterally broken, so... please be prepared."
So much so.
"And now, there is still no news about him."
Rising to a higher level.
"See you then!"
His stance currently seems to be that of a relatively neutral journal.
And this time!
Qin Shiming also received a call from Bird.
Therefore, The Lancet has also gained a large number of readers and fans.
"Observation and exploration of the inefficiency of targeted drugs under the second-generation sequencing technology of NMPA Company!"
First up is the first article.
There was silence in the room, and everyone was reading the article silently.
“Everyone, watch carefully!”
"Let's see who has the patience to win this confrontation!"
"If there is a problem with the second-generation sequencing, they will naturally suffer a lot of losses."
"I think we may have a misunderstanding!"
He had obviously anticipated what would develop next.
"Moreover, without us, it will be more difficult for their drugs to be better tested, and it will be even more difficult to get FDA approval!"
Even, including Bird, the same is true.
And the most important thing is that in this journal, a lot of words are used to analyze Chen Nan's remarks this time!
Second-generation sequencing technology is the main core of the discussion in this journal.
but!
"We just have to be patient and wait..."
This is indeed good news.
"The Lancet"!
They never expected that this time the war in the field of oncology would spread directly to The Lancet.
They went to see an old gentleman at the same time.
When topics like this start to come up.
Bird's eyes were full of fighting spirit. It had been a long time since he had fought such a tough battle. He couldn't lose!
Bird's eyes were full of sharpness and he said sternly: "Contact Pfizer, Johnson & Johnson, Roche...these pharmaceutical companies!"
But……
Waiting for death?
To be honest, he really looked down on the next-generation sequencing, and even less on the NMPA company.
It is also a discussion about the future direction of cancer treatment.
This time, Germany's fate made many people realize: "Times may have changed!"
Compared to the long-established behemoths Gilead and NMPA, Chen Nan seems to be more down-to-earth.
The major oncology journals have more or less begun to increase the number of pages and content in the latest issues of articles.
"It's The Lancet!"
He asked straight to the point:
“Is there really hope for third-generation sequencing?”
Everyone is a little tired!
And just at this time!
Bird suddenly said, he looked at Morton and said with a cold voice:
But!
There are numerous comments and participants at the International Cancer Forum.
Their member countries themselves have institutions that are good at sequencing.
Germany is even more thorough this time: "Temporarily suspending all NMPA's gene sequencing business in Germany."
…
In fact, most oncologists in the world do not understand many things about genetic testing.
But what now?
Qin Shiming just smiled faintly.
Experts started a war of words.
"Show me if there is academic fraud, falsification of data, or other issues!"
I have done it nearly twenty times and got checked out twice.
The famous genetic testing expert, an expert in genetic engineering at the University of California, Los Angeles, made a statement:
"If third-generation sequencing appears now, we will support it!"
"To say that the other party is a castle in the air!"
As for Kong Xu, after returning to China on the plane that day, he led his team to start discussions with Qin Shiming.
No doubt about it!
"I guarantee, Mr. Bird, that during our cooperation, China did not obtain our core technology."
During this time, everyone has participated in this second-generation sequencing defense battle.
The cover has an eye-catching large character.
The academic war is an academic confrontation with experts as the leaders and journals as the platform!
"Did the second-generation sequencing conceal a lie? Or... was it a scam spun by the NMPA company?"
Academic competition is no different from war. You can’t see the smoke of gunpowder, but there is a battle of ideas everywhere!
Qin Shiming and Liao Wenkai were quickly released after being investigated.
After reading it, Tashi suddenly recalled what happened back then.
"Starting today, our National Health Commission will independently use our own sequencing facility!"
…
…
ps: My grandma has a funeral today, so I’m a little tired and can’t write much.